Home Increased serum maternal levels of the HER2 oncoprotein p105 ectodomain in preeclampsia
Article
Licensed
Unlicensed Requires Authentication

Increased serum maternal levels of the HER2 oncoprotein p105 ectodomain in preeclampsia

  • Chantal Tse , Guillaume Lefevre , Nadia Berkane , Antoine Flahault , Karine Toumi , Didier Brault , Jacqueline Capeau and Serge Uzan
Published/Copyright: June 1, 2005

Abstract

HER2/ERBB2 protein is a 185 kDa transmembrane growth factor receptor whose extracellular domain, a 105 kDa fragment (p105), can be released from cell surfaces by proteolytic cleavage. The aim of our study was to compare serum p105 concentrations in normal and pathological pregnancies and to determine whether any correlation exists between preeclampsia and p105 levels. Serum p105 was assayed in 96 nonpregnant women and 89 pregnant women (26 normotensive, 14 normotensive with a history of preeclampsia or fetal hypotrophy, 10 with chronic hypertension, 10 with gestational hypertension and 29 with preeclampsia). Median serum p105 levels (median; 95% confidence interval) were higher in the preeclampsia group (13.9 μg/l; 12.8–16.1 μg/l) than in the normotensive (11.7 μg/l; 10.6μ13.3 μg/l; p<0.05) or non-pregnant groups (9.3 μg/l; 8.9–9.6 μg/l; p<0.001). There were no significant differences between the other pregnancy groups. In the normotensive group, serum p105 was correlated with the number of gestations (r=0.46; p<0.05), parity (r=0.39; p<0.05) and placenta weight (r=0.61; p<0.05). In preeclamptic women, serum p105 correlated with parity (r=0.46; p<0.05). Serum p105 concentrations above 11.9 μg/l were associated with a high odds ratio (OR) for onset of preeclampsia (after adjustment for parity OR=9.0; 95% CI=2.3–36.0; p<0.005). Preeclampsia is associated with increased serum p105 concentrations, which may be related to increased fetomaternal cell traffic.

Published Online: 2005-6-1
Published in Print: 2004-2-18

Copyright © 2004 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives
  2. Regulation of inflammatory responses by activated protein C: the molecular mechanism(s) and therapeutic implications
  3. Increased serum maternal levels of the HER2 oncoprotein p105 ectodomain in preeclampsia
  4. Determination of urinary glyoxal and methylglyoxal by high-performance liquid chromatography
  5. Antioxidants in patients with hyperthyroidism
  6. Biochemical diagnosis of impaired left ventricular ejection fraction - comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP)
  7. Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status
  8. Concomitant isolation of protein C inhibitor and unnicked β2-glycoprotein I
  9. Decreased expression of the insulin-like growth factor-I-binding protein-1 (IGFBP-1) phosphoisoform in pre-eclamptic Wharton's jelly and its role in the regulation of collagen biosynthesis
  10. Urine albumin excretion in acute ischaemic stroke is related to serum interleukin-6
  11. Diagnostic use of cerebral and extracerebral oxysterols
  12. Immunoglobulin G Fcγ receptor expression on polymorphonuclear cells in bronchoalveolar lavage fluid of HIV-infected and HIV-seronegative patients with bacterial pneumonia
  13. The discordance rate, a new concept for combining diagnostic decisions with analytical performance characteristics. 2. Defining analytical goals applied to the diagnosis of type 2 diabetes by blood glucose concentrations
  14. Effects of some pre-analytical conditions on the measurement of homocysteine and cysteine in plasma
  15. Testing and validating a homogeneous immunometric assay for interference
  16. Linearity evaluation of analytical methods that count particles
  17. Environmental dichlorodiphenyltrichlorethane or hexachlorobenzene exposure and breast cancer: is there a risk?
  18. Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer
  19. Distribution of low-density lipoprotein particle size in healthy Korean adult males
  20. Management of invalid internal controls in the Cobas Amplicor HCV-RNA test using the high-speed centrifugation method
  21. The phenomenon of regression-toward-the-mean
  22. Error messages when calculating chi-square statistics with Microsoft EXCEL®
  23. Meetings and Awards
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2004.026/html
Scroll to top button